Valor de la proteína STAT3 como factor pronóstico en el carcinoma renal de célula clara. Revisión sistemática
- 1 April 2019
- journal article
- review article
- Published by Elsevier in Actas Urológicas Españolas
- Vol. 43 (3) , 118-123
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- HAVCR/KIM-1 Activates the IL-6/STAT-3 Pathway in Clear Cell Renal Cell Carcinoma and Determines Tumor Progression and Patient OutcomeCancer Research, 2014
- Comprehensive molecular characterization of clear cell renal cell carcinomaNature, 2013
- Hepatitis A virus cellular receptor 1/kidney injury molecule-1 is a susceptibility gene for clear cell renal cell carcinoma and hepatitis A virus cellular receptor/kidney injury molecule-1 ectodomain shedding a predictive biomarker of tumour progressionEuropean Journal of Cancer, 2013
- STAT3 Polymorphism Can Predict the Response to Interferon-α Therapy in Patients with Metastatic Renal Cell CarcinomaEuropean Urology, 2013
- Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cellsOncogene, 2011
- Signaling pathways in renal cell carcinomaCancer Biology & Therapy, 2010
- Classification of renal cell carcinoma based on expression of VEGF and VEGF receptors in both tumor cells and endothelial cellsLaboratory Investigation, 2008
- STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cellsThe FASEB Journal, 2005
- Human Kidney Injury Molecule-1 Is a Tissue and Urinary Tumor Marker of Renal Cell CarcinomaJournal of the American Society of Nephrology, 2005
- Hepatitis A virus receptor blocks cell differentiation and is overexpressed in clear cell renal cell carcinomaKidney International, 2004